We are live on ! Find out more
ALNA

Allena Pharmaceuticals
ALNA

Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

2 hedge funds and large institutions have $4K invested in Allena Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% less funds holding

Funds holding: 25 → 2 (-23)

100% less capital invested

Capital invested by funds: $1.71M → $4K (-$1.7M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 23

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-23
Holders Change %
-92%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP II
Massachusetts
-$533K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$512K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$135K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$73K
5
TSS
Two Sigma Securities
New York
-$68K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$4K -$135K -1,013,378 -81%
TGI
2
TRV GP II
Massachusetts
– -$533K -2,790,964 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$512K -2,682,145 Closed
Geode Capital Management
4
Geode Capital Management
Massachusetts
– -$73K -386,352 Closed
TSS
5
Two Sigma Securities
New York
– -$68K -357,044 Closed
BlackRock
6
BlackRock
New York
– -$44K -228,215 Closed
State Street
7
State Street
Massachusetts
– -$39K -205,058 Closed
Citigroup
8
Citigroup
New York
– -$33K -174,988 Closed
Millennium Management
9
Millennium Management
New York
– -$33K -173,798 Closed
KAS
10
Kestra Advisory Services
Texas
– -$31K -164,662 Closed
Fidelity Investments
11
Fidelity Investments
Massachusetts
– -$20K -106,183 Closed
Northern Trust
12
Northern Trust
Illinois
– -$17K -89,363 Closed
UBS Group
13
UBS Group
Switzerland
– -$16K -83,827 Closed
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
– -$13K -65,789 Closed
LFAS
15
Level Four Advisory Services
Texas
– -$8K -40,000 Closed
Osaic Holdings
16
Osaic Holdings
Arizona
– -$6K -33,000 Closed
LPL Financial
17
LPL Financial
California
– -$6K -30,550 Closed
GG
18
Golden Green
South Carolina
– -$5K -25,000 Closed
Renaissance Technologies
19
Renaissance Technologies
New York
– -$3K -17,200 Closed
PFS
20
Prospera Financial Services
Texas
– -$2K -10,800 Closed
SWM
21
Spire Wealth Management
Virginia
– -$2K -10,053 Closed
Bank of America
22
Bank of America
North Carolina
– -$1K -5,800 Closed

ALNA Hedge Fund Activity: Q3 2022 in Review

2 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q3 2022, worth a combined $4K — down 100% from $1.71M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ALNA and 0 opened new positions — a net loss of 23 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was TRV GP II, exiting entirely with an estimated $533K sold.

  • 2 institutional investors held Allena Pharmaceuticals (ALNA) as of Q3 2022, down from 25 in Q2 2022.
  • Funds reported $4K of Allena Pharmaceuticals stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Allena Pharmaceuticals positions in Q3 2022 and 23 closed out, a net change of -23 holders.
  • The largest Allena Pharmaceuticals seller in Q3 2022 was TRV GP II, an estimated $533K sold.

Based on aggregated 13F filings for Q3 2022.